![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/09/2879121/0/en/Eton-Pharmaceuticals-Reports-First-Quarter-2024-Financial-Results.html
https://www.globenewswire.com/news-release/2024/05/01/2873607/0/en/Eton-Pharmaceuticals-to-Present-at-the-Citizens-JMP-Life-Sciences-Conference.html
https://www.globenewswire.com/news-release/2024/04/30/2872041/0/en/Eton-Pharmaceuticals-Announces-Submission-to-FDA-of-New-Drug-Application-for-ET-400-Hydrocortisone-Oral-Solution.html
https://www.globenewswire.com/news-release/2024/04/29/2871668/0/en/Eton-Pharmaceuticals-to-Report-First-Quarter-2024-Financial-Results-on-Thursday-May-9-2024.html
https://www.accesswire.com/845736/relief-therapeutics-enters-into-exclusive-us-license-and-supply-agreement-with-eton-pharmaceuticals-for-pku-golike
https://www.globenewswire.com/news-release/2024/03/22/2850741/0/en/Eton-Pharmaceuticals-Announces-Acquisition-of-PKU-GOLIKE-for-Phenylketonuria.html
https://www.globenewswire.com//news-release/2024/03/14/2846673/0/en/Eton-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/29/2838373/0/en/Eton-Pharmaceuticals-to-Report-Fourth-Quarter-and-Full-Year-2023-Financial-Results-on-Thursday-March-14-2024.html
https://www.globenewswire.com//news-release/2024/02/21/2832591/0/en/Eton-Pharmaceuticals-Awarded-U-S-Patent-for-Proprietary-Hydrocortisone-Oral-Liquid-Formulation.html
https://www.globenewswire.com//news-release/2024/02/02/2822744/0/en/Eton-Pharmaceuticals-Announces-Commercial-Availability-of-Ultra-Rare-Disease-Product-Nitisinone-Capsules.html